{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:06:19Z","timestamp":1790424379012,"version":"4.1.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Egyptian Atomic Energy Authority"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03441-3","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T20:45:27Z","timestamp":1778186727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Engineering Bilosomal Nanocarriers for Targeted Delivery of Resveratrol: Rational Design, Radiotracking Insights and Cytotoxic Assessment"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5884-4615","authenticated-orcid":false,"given":"Khaled M.","family":"Attallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2234-6291","authenticated-orcid":false,"given":"Shymaa","family":"Hatem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1995-8537","authenticated-orcid":false,"given":"Marwa Eid","family":"Sayyed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"3441_CR1","doi-asserted-by":"publisher","unstructured":"Gholamreza G, Fatemeh\u00a0R, Reza GK, Malekzadeh M. Colorectal Cancer: Epidemiology, Risk Factors, and Prevention. Cancers (Basel). 2024;16(8):1530. https:\/\/doi.org\/10.3390\/cancers16081530.","DOI":"10.3390\/cancers16081530"},{"issue":"7","key":"3441_CR2","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.3390\/app14072930","volume":"14","author":"P Pieni\u0105dz","year":"2024","unstructured":"Pieni\u0105dz P, Pi\u0119t M, Paduch R. Characteristics of the Colorectal Cancer Microenvironment\u2014Role in Cancer Progression and Therapeutic Possibilities. Appl Sci. 2024;14(7):2930. https:\/\/doi.org\/10.3390\/app14072930.","journal-title":"Appl Sci"},{"issue":"6","key":"3441_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/pharmaceutics16060761","volume":"16","author":"D Unnikrishnan Meenakshi","year":"2014","unstructured":"Unnikrishnan Meenakshi D, Narde GK, Ahuja A, Al Balushi K, Francis AP, Khan SA. Therapeutic Applications of Nanoformulated Resveratrol and Quercetin Phytochemicals in Colorectal Cancer, An Updated Review. Pharmaceutics. 2014;16(6):761. https:\/\/doi.org\/10.3390\/pharmaceutics16060761.","journal-title":"Pharmaceutics"},{"key":"3441_CR4","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J for Clin. 2021;71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660.","DOI":"10.3322\/caac.21660"},{"key":"3441_CR5","doi-asserted-by":"publisher","unstructured":"\u00a0Huang Z, Yang, M. Molecular Network of Colorectal Cancer and Current Therapeutic Options. Front. Oncol. 2022;12:852927. https:\/\/doi.org\/10.3389\/fonc.2022.852927. eCollection 2022.","DOI":"10.3389\/fonc.2022.852927"},{"issue":"3","key":"3441_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/gutjnl-2019-319915","volume":"69","author":"KJ Monahan","year":"2020","unstructured":"Monahan KJ, Bradshaw N, Dolwani S, Desouza B, Dunlop MG, East JE, et al. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)\/Association of Coloproctology of Great Britain and Ireland (ACPGBI)\/United Kingdom cancer genetics group (UKCGG). Gut. 2020;69(3):411\u201344. https:\/\/doi.org\/10.1136\/gutjnl-2019-319915.","journal-title":"Gut"},{"issue":"18","key":"3441_CR7","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.3390\/cancers13184514","volume":"13","author":"P Garcia-Alfonso","year":"2021","unstructured":"Garcia-Alfonso P, Munoz A, Jimenez-Castro J, Jimenez-Fonseca P, Pericay C, Longo-Munoz F, et al. Early Clinical Experience with Trifluridine\/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study. Cancers. 2021;13(18):4514. https:\/\/doi.org\/10.3390\/cancers13184514.","journal-title":"Cancers"},{"issue":"5","key":"3441_CR8","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1053\/j.gastro.2018.12.006","volume":"156","author":"L Fuccio","year":"2019","unstructured":"Fuccio L, Rex D, Ponchon T, Frazzoni L, Dinis-Ribeiro M, Bhandari P, et al. New and recurrent colorectal cancers after resection: a systematic review and meta-analysis of endoscopic surveillance studies. Gastroenterology. 2019;156(5):1309\u201323. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.006.","journal-title":"Gastroenterology"},{"issue":"9","key":"3441_CR9","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.3390\/cancers12092350","volume":"12","author":"R Cohen","year":"2020","unstructured":"Cohen R, Pudlarz T, Delattre JF, Colle R, Andr\u00e9 T. Molecular targets for the treatment of metastatic colorectal cancer. Cancers. 2020;12(9):2350. https:\/\/doi.org\/10.3390\/cancers12092350.","journal-title":"Cancers"},{"key":"3441_CR10","doi-asserted-by":"publisher","unstructured":"Annaji M, Poudel I, Boddu SH, Arnold RD, Tiwari AK, Babu RJ. Resveratrol\u2010loaded nanomedicines for cancer applications. Cancer reports. 2021;4(3):e1353. 2021:4(3):e1353. https:\/\/doi.org\/10.1002\/cnr2.1353.","DOI":"10.1002\/cnr2.1353"},{"key":"3441_CR11","doi-asserted-by":"publisher","first-page":"1516609","DOI":"10.3389\/fphar.2024.1516609","volume":"15","author":"P Wang","year":"2025","unstructured":"Wang P, Li Z, Song Y, Zhang B, Fan C. Resveratrol-driven macrophage polarization: Unveiling mechanisms and therapeutic potential. Front Pharmacol. 2025;15:1516609. https:\/\/doi.org\/10.3389\/fphar.2024.1516609.","journal-title":"Front Pharmacol"},{"key":"3441_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113274","volume":"153","author":"M Roshani","year":"2022","unstructured":"Roshani M, Jafari A, Loghman A, Sheida AH, Taghavi T, Zadeh SS, et al. Applications of resveratrol in the treatment of gastrointestinal cancer. Biomed Pharmacother. 2022;153:113274. https:\/\/doi.org\/10.1016\/j.biopha.2022.113274.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3441_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12935-019-0906-y","volume":"19","author":"M Honari","year":"2019","unstructured":"Honari M, Shafabakhsh R, Reiter RJ, Mirzaei H, Asemi Z. Resveratrol is a promising agent for colorectal cancer prevention and treatment: focus on molecular mechanisms. Cancer Cell Int. 2019;19(1):180. https:\/\/doi.org\/10.1186\/s12935-019-0906-y.","journal-title":"Cancer Cell Int"},{"issue":"23","key":"3441_CR14","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.3390\/nu14235171","volume":"14","author":"Y Cao","year":"2022","unstructured":"Cao Y, Han S, Lu H, Luo Y, Guo T, Wu Q, et al. Targeting mTOR signaling by dietary polyphenols in obesity prevention. Nutrients. 2022;14(23):5171. https:\/\/doi.org\/10.3390\/nu14235171.","journal-title":"Nutrients"},{"issue":"9","key":"3441_CR15","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00726-020-02889-2","volume":"52","author":"B Dariya","year":"2020","unstructured":"Dariya B, Behera SK, Srivani G, Aliya S, Alam A, Nagaraju GP. Resveratrol binds and activates RKIP protein in colorectal cancer. Amino Acids. 2020;52(9):1299\u2013306. https:\/\/doi.org\/10.1007\/s00726-020-02889-2.","journal-title":"Amino Acids"},{"key":"3441_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.670124","volume":"9","author":"K Ying","year":"2021","unstructured":"Ying K, Bai B, Gao X, Xu Y, Wang H, Xie B. Orally administrable therapeutic nanoparticles for the treatment of colorectal cancer. Front Bioeng Biotechnol. 2021;9:670124. https:\/\/doi.org\/10.3389\/fbioe.2021.670124.","journal-title":"Front Bioeng Biotechnol"},{"issue":"4","key":"3441_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16040569","volume":"16","author":"M Salla","year":"2024","unstructured":"Salla M, Karaki N, El Kaderi B, Ayoub AJ, Younes S, Abou Chahla MN, et al. Enhancing the bioavailability of resveratrol: combine it, derivatize it, or encapsulate it? Pharmaceutics. 2024;16(4):569. https:\/\/doi.org\/10.3390\/pharmaceutics16040569.","journal-title":"Pharmaceutics"},{"issue":"5","key":"3441_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/20415990.2025.2469488","volume":"16","author":"MA Obeid","year":"2025","unstructured":"Obeid MA, Ruano-Aldea M, Acevedo R, Schjins V, Alsaadi MM, Ferro VA. Drug delivery systems incorporating bile salts: advancements since the conception of bilosomes. Ther Deliv. 2025;16(5):487\u2013500. https:\/\/doi.org\/10.1080\/20415990.2025.2469488.","journal-title":"Ther Deliv"},{"key":"3441_CR19","doi-asserted-by":"publisher","unstructured":"Kumar D, Tiwari S. Bile salts trigger deformability in liposomal vesicles through edge-activating action. Molecular Pharmaceutics. 2025;22;22(7):3860\u20133867. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c00129.","DOI":"10.1021\/acs.molpharmaceut.5c00129"},{"key":"3441_CR20","doi-asserted-by":"publisher","unstructured":"Emzhik M, Qaribnejad A, Haeri A, Dadashzadeh S. Bile salt-enriched vs. non-enriched nanoparticles: comparison of their physicochemical characteristics and release pattern. Pharmaceutical Development and Technology. 2024;29(3):187\u2013211. https:\/\/doi.org\/10.1080\/10837450.2024.2320279.","DOI":"10.1080\/10837450.2024.2320279"},{"key":"3441_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106259","volume":"176","author":"F Hameedat","year":"2022","unstructured":"Hameedat F, Pizarroso NA, Teixeira N, Pinto S, Sarmento B. Functionalized FcRn-targeted nanosystems for oral drug delivery: a new approach to colorectal cancer treatment. Eur J Pharm Sci. 2022;176:106259. https:\/\/doi.org\/10.1016\/j.ejps.2022.106259.","journal-title":"Eur J Pharm Sci"},{"key":"3441_CR22","doi-asserted-by":"publisher","unstructured":"Nayak D, Rathnanand M, Tippavajhala VK. Unlocking the potential of bilosomes and modified bilosomes: a comprehensive journey into advanced drug delivery trends. AAPS PharmSciTech. 2023:24(8):238. https:\/\/doi.org\/10.1208\/s12249-023-02696-4.","DOI":"10.1208\/s12249-023-02696-4"},{"issue":"8","key":"3441_CR23","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1080\/02652048.2024.2423618","volume":"41","author":"K Aralelimath","year":"2024","unstructured":"Aralelimath K, Sahoo J, Wairkar SJ. Dermal drug delivery via bilosomes: a synergistic integration for better therapeutic outcomes. J Microencapsul. 2024;41(8):818\u201331. https:\/\/doi.org\/10.1080\/02652048.2024.2423618.","journal-title":"J Microencapsul"},{"issue":"1","key":"3441_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01605-4","volume":"20","author":"S Waheed","year":"2022","unstructured":"Waheed S, Li Z, Zhang F, Chiarini A, Armato U, Wu J. Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery. Journal of Nanobiotechnology. 2022;20(1):395. https:\/\/doi.org\/10.1186\/s12951-022-01605-4.","journal-title":"Journal of Nanobiotechnology"},{"key":"3441_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.102205","volume":"61","author":"Z Iqbal","year":"2021","unstructured":"Iqbal Z, Arafa ES, Kanwal Z, Murtaza G. Smart solution of severe problems: radiolabeled nanocarriers for cancer imaging and therapy. Journal of Drug Delivery Science and Technology. 2021;61:102205. https:\/\/doi.org\/10.1016\/j.jddst.2020.102205.","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"3441_CR26","doi-asserted-by":"publisher","unstructured":"Mitrovi\u0107 D, Zaklan D, \u0110ani\u0107 M, Stanimirov B, Stankov K, Al-Salami H, et al. The Pharmaceutical and Pharmacological Potential Applications of Bilosomes as Nanocarriers for Drug Delivery. Molecules. 2025;30(5)1181. https:\/\/doi.org\/10.3390\/molecules30051181.","DOI":"10.3390\/molecules30051181"},{"key":"3441_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123024","volume":"640","author":"MA Abdelbari","year":"2023","unstructured":"Abdelbari MA, El-Gazar AA, Abdelbary AA, Elshafeey AH, Mosallam S. Brij\u00ae integrated bilosomes for improving the transdermal delivery of niflumic acid for effective treatment of osteoarthritis: In-vitro characterization, ex-vivo permeability assessment, and in-vivo study. Int J Pharm. 2023;640:123024. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123024.","journal-title":"Int J Pharm"},{"key":"3441_CR28","doi-asserted-by":"publisher","unstructured":"Naji GH, Al Gawhari FJc. Evaluation of types and concentration of bile salts impact on physical properties of nisoldipine-loaded bilosomes. Pharmacia. 2024;71:1\u20137. https:\/\/doi.org\/10.3897\/pharmacia.71.e116917.","DOI":"10.3897\/pharmacia.71.e116917"},{"key":"3441_CR29","doi-asserted-by":"publisher","unstructured":"Sabri LA, Khudhair AS. Formulation and In-vitro Evaluation of Nanovesicles Bilosomes Loaded with Ketoconazole. Iraqi Journal of Pharmaceutical Sciences. 2025;34(1):156\u2013164. https:\/\/doi.org\/10.31351\/vol34iss1pp156-164.","DOI":"10.31351\/vol34iss1pp156-164"},{"issue":"4","key":"3441_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1515\/tsd-2024-2595","volume":"61","author":"B Sonule","year":"2024","unstructured":"Sonule B, Mehetre N, Kumar L. Determination of resveratrol in nanoformulations using UV-spectroscopy: forced degradation and drug entrapment. Tenside, Surfactants, Deterg. 2024;61(4):358\u201365. https:\/\/doi.org\/10.1515\/tsd-2024-2595.","journal-title":"Tenside, Surfactants, Deterg"},{"key":"3441_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105400","volume":"92","author":"H Peddapalli","year":"2024","unstructured":"Peddapalli H, Radha GV, Chinnaiyan SK. Formulation optimization and PK\/PD evaluation of novel valsartan bilosomes enhancing transdermal drug delivery. Journal of Drug Delivery Science and Technology. 2024;92:105400. https:\/\/doi.org\/10.1016\/j.jddst.2024.105400.","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"5","key":"3441_CR32","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s13346-020-00708-5","volume":"10","author":"AP Pandit","year":"2020","unstructured":"Pandit AP, Omase SB, Mute VM. A chitosan film containing quercetin-loaded transfersomes for treatment of secondary osteoporosis. Drug Deliv Transl Res. 2020;10(5):1495\u2013506. https:\/\/doi.org\/10.1007\/s13346-020-00708-5.","journal-title":"Drug Deliv Transl Res"},{"key":"3441_CR33","doi-asserted-by":"publisher","unstructured":"Thirumalai A, Harini K, Pallavi P, Gowtham P, Girigoswami K, Girigoswami A. Bile salt-mediated surface-engineered bilosome-nanocarriers for delivering therapeutics. Nanomedicine Journal. 2024:11(1):1\u201311. https:\/\/doi.org\/10.22038\/NMJ.2023.71268.1763","DOI":"10.22038\/NMJ.2023.71268.1763"},{"issue":"1","key":"3441_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s13346-023-01384-x","volume":"14","author":"RK Wassif","year":"2024","unstructured":"Wassif RK, Elkheshen SA, Shamma RN, Amer MS, Elhelw R, El-Kayal M. Injectable systems of chitosan in situ forming composite gel incorporating linezolid-loaded biodegradable nanoparticles for long-term treatment of bone infections. Drug Deliv Transl Res. 2024;14(1):80\u2013102. https:\/\/doi.org\/10.1007\/s13346-023-01384-x.","journal-title":"Drug Deliv Transl Res"},{"issue":"19","key":"3441_CR35","doi-asserted-by":"publisher","first-page":"13875","DOI":"10.2147\/IJN.S477820.eCollection","volume":"2024","author":"X Zhang","year":"2024","unstructured":"Zhang X, Hao J, Lu T, Dong Y, Sun Y, Yu Y, et al. Resveratrol-Loaded Versatile Nanovesicle for Alopecia Therapy via Comprehensive Strategies. Intl J Nanomedicine. 2024;2024(19):13875\u2013900. https:\/\/doi.org\/10.2147\/IJN.S477820.eCollection.","journal-title":"Intl J Nanomedicine"},{"issue":"4","key":"3441_CR36","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1007\/s10787-024-01476-1","volume":"32","author":"Z Wang","year":"2024","unstructured":"Wang Z, Gao C, Zhang L, Sui R. Novel combination of Olesoxime\/Resveratrol-encapsulated exosomes to improve cognitive function by targeting amyloid \u03b2-induced Alzheimer\u2019s disease: investigation on in vitro and in-vivo model. Inflammopharmacology. 2024;32(4):2613\u201328. https:\/\/doi.org\/10.1007\/s10787-024-01476-1.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"3441_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17010123","volume":"17","author":"TT Elebyary","year":"2025","unstructured":"Elebyary TT, Sultan AA, Abu-Risha SE, El Maghraby GM, Amin M. Bilosomal co-encapsulated Tamoxifen and Propranolol for potentiated anti-breast cancer efficacy: in vitro and in-vivo investigation. Pharmaceutics. 2025;17(1):123. https:\/\/doi.org\/10.3390\/pharmaceutics17010123.","journal-title":"Pharmaceutics"},{"key":"3441_CR38","doi-asserted-by":"publisher","unstructured":"Sayyed ME, Abd el-Motaleb M, Ibrahim IT, Rashed HM, El-Nabarawi MA, Ahmed MA. Preparation, characterization, and in-vivo biodistribution study of intranasal 131I-clonazepam-loaded phospholipid magnesome as a promising brain delivery system Biodistribution and pharmacokinetic behavior of intranasal 131I-Clonazepam loaded phospholipid magnesome as a potential brain targeting system. Eur J Pharm Sci. 2022;169:106089. https:\/\/doi.org\/10.1016\/j.ejps.2021.106089.","DOI":"10.1016\/j.ejps.2021.106089"},{"key":"3441_CR39","doi-asserted-by":"publisher","unstructured":"Kabil MF, Attallah KM, El-sherbiny I, Nasr M. Ticagrelor-loaded lipid nanocapsules as a promising nebulizable system for lung cancer: in-vitro characterization, 131I radiolabeling and in-vivo biodistribution. Journal of Drug Delivery Science and Technology. 114, part B; 2025:107560. https:\/\/doi.org\/10.1016\/j.jddst.2025.107560.","DOI":"10.1016\/j.jddst.2025.107560"},{"key":"3441_CR40","doi-asserted-by":"publisher","unstructured":"El-Kawy OA, Ibrahim IT, Shewatah HA, Attalah KM. Preparation and evaluation of radiolabeled gliclazide parenteral nanoemulsion as a new tracer for pancreatic \u03b2-cells mass. Int J Radiat Biol. 2023;99:(11)1738\u20131748. https:\/\/doi.org\/10.1080\/09553002.2023.2204914.","DOI":"10.1080\/09553002.2023.2204914"},{"issue":"1","key":"3441_CR41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s13346-025-01865","volume":"16","author":"RS Abdel-Rashid","year":"2026","unstructured":"Abdel-Rashid RS, El-Leithy ES, Ibrahim IT, Attallah KM. Radiolabelling and bioequivalence of modified Tamoxifen solid lipid nanoparticles as a targeted chemotherapeutic drug. Drug Deliv Transl Res. 2026;16(1):291\u2013302. https:\/\/doi.org\/10.1007\/s13346-025-01865.","journal-title":"Drug Deliv Transl Res"},{"issue":"6","key":"3441_CR42","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.remn.2017.03.001","volume":"36","author":"MA Motaleb","year":"2017","unstructured":"Motaleb MA, Ibrahim IT, Sayyed ME, Awad GA. 131I-trazodone: preparation, quality control and in-vivo biodistribution study by intranasal and intravenous routes as a hopeful brain imaging radiopharmaceutical. Rev Esp Med Nucl Imagen Mol. 2017;36(6):371\u20136. https:\/\/doi.org\/10.1016\/j.remn.2017.03.001.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"3441_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2022.110464","volume":"189","author":"OA El-Kawy","year":"2022","unstructured":"El-Kawy OA, Shweeta HA, Attallah KM. Radioiodination, nasal nanoformulation and preliminary evaluation of isovanillin: a new potential brain cancer-targeting agent. Appl Radiat Isot. 2022;189:110464. https:\/\/doi.org\/10.1016\/j.apradiso.2022.110464.","journal-title":"Appl Radiat Isot"},{"key":"3441_CR44","unstructured":"Al-Gendy A, Moharram F, Zarka M. Chemical composition, antioxidant, cytotoxic and antimicrobial acgsssativities of Pimenta racemosa (Mill.) JW Moore flower essential oil. J Pharmacogn Phytochem. 2017:6(2):312\u2013319."},{"key":"3441_CR45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.toxlet.2018.04.008","volume":"291","author":"RM Allam","year":"2018","unstructured":"Allam RM, Al-Abd AM, Khedr A, Sharaf OA, Nofal SM, Khalifa AE, et al. Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells. Toxicol Lett. 2018;291:77\u201385. https:\/\/doi.org\/10.1016\/j.toxlet.2018.04.008.","journal-title":"Toxicol Lett"},{"issue":"1","key":"3441_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105874","volume":"98","author":"M Nasr","year":"2024","unstructured":"Nasr M, Ibrahim IT, Attallah KM. Design of N-acetylcysteine vesicles as a potential chemopreventive tool in lung cancer: characterization, Tc-99m radiolabeling and in vivo evaluation. J Drug Deliv Sci Technol. 2024;98(1):105874. https:\/\/doi.org\/10.1016\/j.jddst.2024.105874.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"3441_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1023\/A:1015268611569","volume":"252","author":"E El-Ghany","year":"2002","unstructured":"El-Ghany E, Mahdy M, Attallah K, Ghazy F. Preparation of 125I-cytarabine and its radiochemical evaluation: model of radiotherapeutic agent. J Radioanal Nucl Chem. 2002;252(1):165\u20139. https:\/\/doi.org\/10.1023\/A:1015268611569.","journal-title":"J Radioanal Nucl Chem"},{"issue":"22","key":"3441_CR48","doi-asserted-by":"publisher","first-page":"19351","DOI":"10.1021\/acsomega.2c08304","volume":"8","author":"B Mansour","year":"2023","unstructured":"Mansour B, Salem YA, Attallah KM, El-Kawy OA, Ibrahim IT, Abdel-Aziz NI. Cyanopyridinone- and Cyanopyridine-Based Cancer Cell Pim-1 Inhibitors: design, synthesis, radiolabeling, biodistribution, and molecular modeling simulation. ACS Omega. 2023;8(22):19351\u201366. https:\/\/doi.org\/10.1021\/acsomega.2c08304.","journal-title":"ACS Omega"},{"issue":"12","key":"3441_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ph15121577","volume":"15","author":"J Li","year":"2022","unstructured":"Li J, Hu W, Peng J, Wong P, Kandeel F, Olafsen T, et al. Heart uptake of [18F] fluoro-4-thia-oleate in a non-alcoholic fatty liver disease mouse model. Pharmaceuticals. 2022;15(12):1577. https:\/\/doi.org\/10.3390\/ph15121577.","journal-title":"Pharmaceuticals"},{"issue":"3","key":"3441_CR50","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-026-03366-x","volume":"27","author":"S Ahmed","year":"2026","unstructured":"Ahmed S, Attallah KM, Sayyed ME. Engineered novel brijaluronic terpesomes for brain-targeted quercetin delivery: optimization, ex vivo and radiokinetics. AAPS PharmSciTech. 2026;27(3):149. https:\/\/doi.org\/10.1208\/s12249-026-03366-x.","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"3441_CR51","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.apsb.2014.10.005","volume":"4","author":"M Yasir","year":"2014","unstructured":"Yasir M, Sara UV. Solid lipid nanoparticles for nose to brain delivery of haloperidol: in-vitro drug release and pharmacokinetics evaluation. Acta Pharm Sin B. 2014;4(6):454\u201363. https:\/\/doi.org\/10.1016\/j.apsb.2014.10.005.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"3441_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12020107","volume":"12","author":"IS Ahmed","year":"2020","unstructured":"Ahmed IS, Rashed HM, Fayez H, Farouk F, Shamma RN. Nanoparticle-mediated dual targeting: an approach for enhanced baicalin delivery to the liver. Pharmaceutics. 2020;12(2):107. https:\/\/doi.org\/10.3390\/pharmaceutics12020107.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3441_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-025-00775-w","volume":"11","author":"MK Mohsen","year":"2025","unstructured":"Mohsen MK, Diab SA, Shafik AN, Osman AH, Naguib MJ, Kamel AM, et al. Sofosbuvir\u2019s hepatoprotective efficacy in rats is enhanced by encapsulating in taurocholate-stabilized galactose-anchored bilosomes. Future J Pharm Sci. 2025;11(1):21. https:\/\/doi.org\/10.1186\/s43094-025-00775-w.","journal-title":"Future J Pharm Sci"},{"issue":"3","key":"3441_CR54","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1039\/D5PM00025D","volume":"2","author":"H Wankhede","year":"2025","unstructured":"Wankhede H, Penumaka SM, Mandal D, Rojatkar S, Gaikwad V, Patil S. Artesunate-loaded bilosomes with enhanced oral bioavailability: in silico and in vitro study against Leishmania donovani promastigotes and in vivo pharmacokinetic assessment in rats. RSC Pharm. 2025;2(3):541\u201352. https:\/\/doi.org\/10.1039\/D5PM00025D.","journal-title":"RSC Pharm"},{"key":"3441_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104766","volume":"87","author":"MA Obeid","year":"2023","unstructured":"Obeid MA, Ogah CA, Ogah CO, Ajala OS, Aldea MR, Gray AI, et al. Formulation and evaluation of nanosized hippadine-loaded niosome: extraction and isolation, physicochemical properties, and in vitro cytotoxicity against human ovarian and skin cancer cell lines. J Drug Deliv Sci Technol. 2023;87:104766. https:\/\/doi.org\/10.1016\/j.jddst.2023.104766.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3441_CR56","doi-asserted-by":"publisher","unstructured":"Fadel NA, El-Sabbagh WA, Darwish AB, Younis MM. Rosuvastatin loaded bilosomes as an innovative therapeutic approach for radiation-induced cardiovascular alterations by targeting Nrf2\/HO-1 pathway. Egyptian Pharmaceutical Journal. 2025:24(2):274\u2013288. https:\/\/doi.org\/10.21608\/epj.2025.415604.","DOI":"10.21608\/epj.2025.415604"},{"key":"3441_CR57","doi-asserted-by":"publisher","unstructured":"Mondal D, De S. Bile saltbased vesicles a\u2013nanotheranostics perspective. Theranostics Nanomaterials in Drug Delivery. 2025;323\u2013338. https:\/\/doi.org\/10.1016\/B978-0-443-22044-9.00024-3.","DOI":"10.1016\/B978-0-443-22044-9.00024-3"},{"issue":"12","key":"3441_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106463","volume":"104","author":"E Abdelhakeem","year":"2025","unstructured":"Abdelhakeem E, Nemr AA, Rashed HM, Selim AA, Essa BM, Hegazy D. Revitalizing Itraconazole: Unleashing its Anticancer Potential through Oral Nanosystems for Liver Targeting and Biodistribution Profiling in an Animal Model using Radiolabeling Technique. Journal of Drug Delivery Science and Technology. 2025;104(12):106463. https:\/\/doi.org\/10.1016\/j.jddst.2024.106463.","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"2s","key":"3441_CR59","doi-asserted-by":"publisher","DOI":"10.5530\/ijper.20250292","volume":"59","author":"K Santhinathan","year":"2025","unstructured":"Santhinathan K, Durai S, Sirajudeen R, Govindhraji G, Gopal S, Kumararaja G. Bilosome Nanocarriers for Enhanced Oral Bioavailability and Cardiovascular Activity of Milrinone. Indian Journal of Pharmaceutical Education and Research. 2025;59(2s):s436\u2013s442. https:\/\/doi.org\/10.5530\/ijper.20250292.","journal-title":"Indian Journal of Pharmaceutical Education and Research"},{"issue":"4","key":"3441_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17040464","volume":"17","author":"S Jacob","year":"2025","unstructured":"Jacob S, Kather FS, Boddu SH, Rao R, Nair AB. Vesicular Carriers for Phytochemical Delivery: A Comprehensive Review of Techniques and Applications. Pharmaceutics. 2025;17(4):464. https:\/\/doi.org\/10.3390\/pharmaceutics17040464.","journal-title":"Pharmaceutics"},{"key":"3441_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106879","volume":"108","author":"K Pawar","year":"2025","unstructured":"Pawar K, Kamble R, Patil S. Linagliptin-Loaded Bilosomes for Oral Administration: Formulation, Optimization by Box-Behnken Design, In-vitro, and In-vivo Assessment. Journal of Drug Delivery Science and Technology. 2025;108:106879. https:\/\/doi.org\/10.1016\/j.jddst.2025.106879.","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"2","key":"3441_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17020193","volume":"17","author":"M Tripathi","year":"2025","unstructured":"Tripathi M, Gharti L, Bansal A, Kaurav H, Sheth S. Intranasal Mucoadhesive In Situ Gel of Glibenclamide-Loaded Bilosomes for Enhanced Therapeutic Drug Delivery to the Brain. Pharmaceutics. 2025;17(2):193. https:\/\/doi.org\/10.3390\/pharmaceutics17020193.","journal-title":"Pharmaceutics"},{"key":"3441_CR63","doi-asserted-by":"publisher","unstructured":"Abdullah HD, Kamal I, Sabry SA, Abd Elghany M, El hakim Ramadan A. Effective tailoring of cefepime into bilosomes: A promising nanoplatform for enhancing oral absorption, extending half-life, and evaluating biocompatibility, antibacterial, anti-biofilm, anti-breast cancer activity, ex-vivo, and in-vivo studies. Int J Pharm. 2025;668:125001. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.125001.","DOI":"10.1016\/j.ijpharm.2024.125001"},{"key":"3441_CR64","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.2147\/IJN.S319255","volume":"16","author":"M El-Nabarawi","year":"2021","unstructured":"El-Nabarawi M, Nafady M, Elmenshawe S, Elkarmalawy M, Teaima M. Liver targeting of Daclatasvir via tailoring sterically stabilized bilosomes: fabrication, comparative in Vitro\/In vivo appraisal and biodistribution studies. Int J Nanomedicine. 2021;16:6413\u201326. https:\/\/doi.org\/10.2147\/IJN.S319255.","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"3441_CR65","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02747-4","volume":"25","author":"R Maheshwari","year":"2024","unstructured":"Maheshwari R, Bhatt LK, Wairkar S. Enhanced oral bioavailability of progesterone in bilosome formulation: fabrication, statistical optimization, and pharmacokinetic study. AAPS PharmSciTech. 2024;25(2):29. https:\/\/doi.org\/10.1208\/s12249-024-02747-4.","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"3441_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13040451","volume":"13","author":"B Szulc-Musio\u0142","year":"2021","unstructured":"Szulc-Musio\u0142 B, Sarecka-Hujar B. The use of micro-and nanocarriers for resveratrol delivery into and across the skin in different skin diseases\u2014A literature review. Pharmaceutics. 2021;13(4):451. https:\/\/doi.org\/10.3390\/pharmaceutics13040451.","journal-title":"Pharmaceutics"},{"issue":"8","key":"3441_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103522","volume":"74","author":"LM Khalil","year":"2022","unstructured":"Khalil LM, Abdallah OY, Elnaggar YS, El-Refaie WM. Novel dermal nanobilosomes with promising browning effect of adipose tissue for management of obesity. J Drug Deliv Sci Technol. 2022;74(8):103522. https:\/\/doi.org\/10.1016\/j.jddst.2022.103522.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3441_CR68","doi-asserted-by":"publisher","unstructured":"Al-Edhari GH, Al Gawhari FJ. Study the effect of formulation variables on preparation of nisoldipine loaded nano bilosomes. Iraqi Journal of Pharmaceutical Sciences. 32(Suppl.) (2023) 271\u2013282. https:\/\/doi.org\/10.31351\/vol32issSuppl.pp271-282.","DOI":"10.31351\/vol32issSuppl.pp271-282"},{"issue":"6","key":"3441_CR69","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3390\/polym15061464","volume":"15","author":"RA Youness","year":"2023","unstructured":"Youness RA, Al-Mahallawi AM, Mahmoud FH, Atta H, Braoudaki M, Fahmy SA. Oral delivery of psoralidin by mucoadhesive surface-modified bilosomes showed boosted apoptotic and necrotic effects against breast and lung cancer cells. Polymers. 2023;15(6):1464. https:\/\/doi.org\/10.3390\/polym15061464.","journal-title":"Polymers"},{"issue":"4","key":"3441_CR70","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/08853282231198948","volume":"38","author":"A Naseri","year":"2023","unstructured":"Naseri A, Taymouri S, Hosseini Sharifabadi A, Varshosaz J. Chrysin loaded bilosomes improve the hepatoprotective effects of chrysin against CCl4 induced hepatotoxicity in mice. Biomater Appl. 2023;38(4):509\u201326. https:\/\/doi.org\/10.1177\/08853282231198948.","journal-title":"Biomater Appl"},{"issue":"1","key":"3441_CR71","doi-asserted-by":"publisher","first-page":"2162157","DOI":"10.1080\/10717544.2022.2162157","volume":"30","author":"MY Zakaria","year":"2023","unstructured":"Zakaria MY, Abd El-Halim SM, Beshay BY, Zaki I, Abourehab MA. Poly phenolic phytoceutical loaded nano-bilosomes for enhanced caco-2 cell permeability and SARS-CoV 2 antiviral activity: in-vitro and insilico studies. Drug Delivery. 2023;30(1):2162157. https:\/\/doi.org\/10.1080\/10717544.2022.2162157.","journal-title":"Drug Delivery"},{"issue":"1","key":"3441_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08982104.2019.1577256","volume":"30","author":"MA El-Nabarawi","year":"2020","unstructured":"El-Nabarawi MA, Shamma RN, Farouk F, Nasralla SM. Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and in vivo skin deposition assay. J Liposome Res. 2020;30(1):1\u201311. https:\/\/doi.org\/10.1080\/08982104.2019.1577256.","journal-title":"J Liposome Res"},{"key":"3441_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115757","volume":"168","author":"AJ Alamoudi","year":"2023","unstructured":"Alamoudi AJ, Badr-Eldin SM, Ahmed OA, Fahmy UA, Elbehairi SE, Alfaifi MY, et al. Optimized bilosome-based nanoparticles enhance cytotoxic and pro-apoptotic activity of costunolide in LS174T colon cancer cells. Biomed Phar. 2023;168:115757. https:\/\/doi.org\/10.1016\/j.biopha.2023.115757.","journal-title":"Biomed Phar"},{"issue":"03","key":"3441_CR74","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1055\/s-0042-1757969","volume":"13","author":"VA Narayanan","year":"2023","unstructured":"Narayanan VA, Sharma A, John A. Bilosomes as a potential carrier to enhance cognitive effects of Bacopa monnieri extract on oral administration. Journal of Health and Allied Sciences NU. 2023;13(03):421\u201330. https:\/\/doi.org\/10.1055\/s-0042-1757969.","journal-title":"Journal of Health and Allied Sciences NU"},{"key":"3441_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122776","volume":"635","author":"AH AbuBakr","year":"2023","unstructured":"AbuBakr AH, Hassan HA, Abdalla A, Khowessah OM, Abdelbary GA. Therapeutic potential of cationic bilosomes in the treatment of carrageenan-induced rat arthritis via fluticasone propionate gel. Int J Pharm. 2023;635:122776. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122776.","journal-title":"Int J Pharm"},{"key":"3441_CR76","doi-asserted-by":"publisher","unstructured":"Abou Assi R, Abdulbaqi IM, Tan SM, Wahab HA, Darwis Y, Chan SY. Breaking barriers: bilosomes gel potentials to pave the way for transdermal breast cancer treatment with tamoxifen. Drug Dev Ind Pharm. 2023;1\u201312. https:\/\/doi.org\/10.1080\/03639045.2023.2256404.","DOI":"10.1080\/03639045.2023.2256404"},{"key":"3441_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121717","volume":"619","author":"H Hegazy","year":"2022","unstructured":"Hegazy H, Amin MM, Fayad W, Zakaria MY. TPGS surface modified bilosomes as boosting cytotoxic oral delivery systems of curcumin against doxorubicin resistant MCF-7 breast cancer cells. Int J Pharm. 2022;619:121717. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121717.","journal-title":"Int J Pharm"},{"key":"3441_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120294","volume":"596","author":"R Lorenzoni","year":"2021","unstructured":"Lorenzoni R, Contri RV, de Lima CK, Barreto F, de Araujo BV, Pohlmann AR, et al. Dermatopharmacokinetic and pharmacodynamic evaluation of a novel nanostructured formulation containing capsaicinoids for treating neuropathic pain. International Journal of Pharmaceutics. 2021;596:120294. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120294.","journal-title":"International Journal of Pharmaceutics"},{"key":"3441_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123385","volume":"646","author":"MY Zakaria","year":"2023","unstructured":"Zakaria MY, Sharaky M, Noreddin AM, Alnajjar R, El-Shesheny R, Kutkat O, et al. Investigating the superiority of chitosan\/D-alpha-tocopheryl polyethylene glycol succinate binary coated bilosomes in promoting the cellular uptake and anti-SARS-CoV-2 activity of polyphenolic herbal drug candidate. Int J Pharm. 2023;646:123385. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123385.","journal-title":"Int J Pharm"},{"issue":"3","key":"3441_CR80","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1089\/cbr.2021.0233","volume":"37","author":"K Kumar","year":"2022","unstructured":"Kumar K. Radioiodine labeling reagents and methods for new chemical entities and biomolecules. Cancer Biotherapy and Radiopharmaceuticals. 2022;37(3):173\u201385. https:\/\/doi.org\/10.1089\/cbr.2021.0233.","journal-title":"Cancer Biotherapy and Radiopharmaceuticals"},{"issue":"2","key":"3441_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26020414","volume":"26","author":"K Kumar","year":"2021","unstructured":"Kumar K, Ghosh A. Radiochemistry, production processes, labeling methods, and immunoPET imaging pharmaceuticals of iodine-124. Molecules. 2021;26(2):414. https:\/\/doi.org\/10.3390\/molecules26020414.","journal-title":"Molecules"},{"key":"3441_CR82","doi-asserted-by":"publisher","unstructured":"Petrov SA, Yusubov MS, Beloglazkina EK, Nenajdenko VG. Synthesis of radioiodinated compounds. Classical approaches and achievements of recent years. International Journal of Molecular Sciences. 2022;23(22):13789. https:\/\/doi.org\/10.3390\/ijms232213789.","DOI":"10.3390\/ijms232213789"},{"issue":"19","key":"3441_CR83","doi-asserted-by":"publisher","first-page":"11108","DOI":"10.1021\/acs.chemrev.4c00303","volume":"124","author":"A Yoshimura","year":"2024","unstructured":"Yoshimura A, Zhdankin VV. Recent progress in synthetic applications of hypervalent iodine (III) reagents. Chemical Reviews. 2024;124(19):11108\u201386. https:\/\/doi.org\/10.1021\/acs.chemrev.4c00303.","journal-title":"Chemical Reviews"},{"issue":"8","key":"3441_CR84","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jsps.2018.06.001","volume":"26","author":"R Al-Salahi","year":"2018","unstructured":"Al-Salahi R, Moustapha ME, Abuelizz HA, Alharthi AI, Alburikan KA, Ibrahim IT, et al. Radioiodination and biodistribution of newly synthesized 3-benzyl-2-([3-methoxybenzyl]thio)benzo[g]quinazolin-4-(3H)-one in tumor bearing mice. Saudi Pharmaceutical Journal. 2018;26(8):1120\u20136. https:\/\/doi.org\/10.1016\/j.jsps.2018.06.001.","journal-title":"Saudi Pharmaceutical Journal"},{"issue":"12","key":"3441_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121572","volume":"17","author":"AR Said","year":"2024","unstructured":"Said AR, Arafa MF, El-Dakroury WA, Alshehri S, El Maghraby GM. Bilosomes and Niosomes for Enhanced Intestinal Absorption and In Vivo Efficacy of Cytarabine in Treatment of Acute Myeloid Leukemia. Pharmaceuticals. 2024;17(12):1572. https:\/\/doi.org\/10.3390\/ph17121572.","journal-title":"Pharmaceuticals"},{"issue":"17","key":"3441_CR86","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.3390\/molecules27175429","volume":"27","author":"C Stokke","year":"2022","unstructured":"Stokke C, Kvassheim M, Blakkisrud J. Radionuclides for targeted therapy: physical properties. Molecules. 2022;27(17):5429. https:\/\/doi.org\/10.3390\/molecules27175429.","journal-title":"Molecules"},{"issue":"4","key":"3441_CR87","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1134\/S1066362220040104","volume":"62","author":"ME Moustapha","year":"2020","unstructured":"Moustapha ME. Radioiodination of atorvastatin as a model radiopharmaceutical for targeting liver. Radiochemistry. 2020;62(4):532\u20138. https:\/\/doi.org\/10.1134\/S1066362220040104.","journal-title":"Radiochemistry"},{"key":"3441_CR88","doi-asserted-by":"publisher","unstructured":"Nurhidayah W, Widyasari EM, Daruwati I, Mahendra I, Subroto T, Khairul Ikram NK, Muchtaridi M. Radiosynthesis, stability, lipophilicity, and cellular uptake evaluations of [131I] Iodine-\u03b1-mangostin for breast cancer diagnosis and therapy. International Journal of Molecular Sciences. 2023;12;24(10):8678. https:\/\/doi.org\/10.3390\/ijms24108678.","DOI":"10.3390\/ijms24108678"},{"issue":"1","key":"3441_CR89","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12951-024-02309-7","volume":"22","author":"L Zhi","year":"2024","unstructured":"Zhi L, Cheng C, Jing L, Zhi-Ping P, Lu Y, Yan T, et al. Application of fluorocarbon nanoparticles of 131I-fulvestrant as a targeted radiation drug for endocrine therapy on human breast cancer. Journal of Nanobiotechnology. 2024;22(1):107. https:\/\/doi.org\/10.1186\/s12951-024-02309-7.","journal-title":"Journal of Nanobiotechnology"},{"issue":"1","key":"3441_CR90","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12951-025-03223-2","volume":"23","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhu C, Huang S, Xu M, Li C, Fu H, et al. Efficient delivery of anlotinib and radioiodine by long circulating nano-capsules for active enhanced suppression of anaplastic thyroid carcinoma. Journal of Nanobiotechnology. 2025;23(1):180. https:\/\/doi.org\/10.1186\/s12951-025-03223-2.","journal-title":"Journal of Nanobiotechnology"},{"key":"3441_CR91","doi-asserted-by":"publisher","unstructured":"Guo J, Xiong H, Liu H, Zhang T, Sun X. Radioiodine based biomedical carriers for cancer theranostics. Coordination Chemistry Reviews. 2023;497:215430. https:\/\/doi.org\/10.1016\/j.ccr.2023.215430.","DOI":"10.1016\/j.ccr.2023.215430"},{"issue":"1","key":"3441_CR92","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10967-015-4140-3","volume":"307","author":"MA Motaleb","year":"2015","unstructured":"Motaleb MA, Abdel-Ghaney IY, Abdel-Bary HM, Shamsel-Din HA. Synthesis, radioiodination and biological evaluation of a novel phthalimide derivative. J Radioanal Nucl Chem. 2015;307(1):363\u201372. https:\/\/doi.org\/10.1007\/s10967-015-4140-3.","journal-title":"J Radioanal Nucl Chem"},{"issue":"6","key":"3441_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12645-023-00157-y","volume":"14","author":"MM Swidan","year":"2023","unstructured":"Swidan MM, Essa BM, Sakr TM. Pristine\/folate-functionalized graphene oxide as two intrinsically radioiodinated nzano-theranostics: self\/dual in vivo targeting comparative study. Cancer Nanotechnol. 2023;14(6):1\u201317. https:\/\/doi.org\/10.1186\/s12645-023-00157-y.","journal-title":"Cancer Nanotechnol"},{"key":"3441_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104404","volume":"83","author":"L Yuan","year":"2023","unstructured":"Yuan L, Chen Q, Riviere JE, Lin Z. Pharmacokinetics and tumor delivery of nanoparticles. J Drug Deliv Sci Technol. 2023;83:104404. https:\/\/doi.org\/10.1016\/j.jddst.2023.104404.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"20","key":"3441_CR95","doi-asserted-by":"publisher","first-page":"19810","DOI":"10.1021\/acsnano.3c04037","volume":"17","author":"Q Chen","year":"2023","unstructured":"Chen Q, Yuan L, Chou WC, Cheng YH, He C, Monteiro-Riviere NA, et al. Meta-Analysis of Nanoparticle Distribution in Tumors and Major Organs in Tumor-Bearing Mice. ACS Nano. 2023;17(20):19810\u201331. https:\/\/doi.org\/10.1021\/acsnano.3c04037.","journal-title":"ACS Nano"},{"issue":"1","key":"3441_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52416-0","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, Hu Y, Zhang X, Shi X, Parak WJ, Pich A. Transvascular transport of nanocarriers for tumor delivery. Nature communications. 2024;15(1):8172. https:\/\/doi.org\/10.1038\/s41467-024-52416-0.","journal-title":"Nature communications"},{"issue":"1","key":"3441_CR97","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2023.2183815","volume":"30","author":"S Batool","year":"2023","unstructured":"Batool S, Sohail S, Ud Din F, Alamri AH, Alqahtani AS, Alshahrani MA, et al. A detailed insight of the tumor targeting using nanocarrier drug delivery system. Drug Deliv. 2023;30(1):2183815. https:\/\/doi.org\/10.1080\/10717544.2023.2183815.","journal-title":"Drug Deliv"},{"issue":"6","key":"3441_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/app15063189","volume":"15","author":"IA Vagena","year":"2025","unstructured":"Vagena IA, Malapani C, Gatou MA, Lagopati N, Pavlatou EA. Enhancement of EPR effect for passive tumor targeting: current status and future perspectives. Applied Sciences. 2025;15(6):3189. https:\/\/doi.org\/10.3390\/app15063189.","journal-title":"Applied Sciences"},{"key":"3441_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.onano.2024.100215","volume":"20","author":"MM Chowdhury","year":"2024","unstructured":"Chowdhury MM, Kubra K, Islam A. Fundamentals behind the success of nanotechnology in cancer treatment and diagnosis. OpenNano. 2024;20:100215. https:\/\/doi.org\/10.1016\/j.onano.2024.100215.","journal-title":"OpenNano"},{"issue":"10","key":"3441_CR100","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/s41563-023-01630-0","volume":"22","author":"LN Nguyen","year":"2023","unstructured":"Nguyen LN, Lin ZP, Sindhwani S, MacMillan P, Mladjenovic SM, Stordy B, et al. The exit of nanoparticles from solid tumours. Nature Materials. 2023;22(10):1261\u201372. https:\/\/doi.org\/10.1038\/s41563-023-01630-0.","journal-title":"Nature Materials"},{"issue":"5","key":"3441_CR101","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","volume":"19","author":"S Sindhwani","year":"2020","unstructured":"Sindhwani S, Syed AM, Ngai J, Kingston BR, Maiorino L, Rothschild J, et al. The entry of nanoparticles into solid tumours. Nature materials. 2020;19(5):566\u201375. https:\/\/doi.org\/10.1038\/s41563-019-0566-2.","journal-title":"Nature materials"},{"key":"3441_CR102","doi-asserted-by":"publisher","DOI":"10.37349\/etat.2025.1002355","volume":"6","author":"D Singh","year":"2025","unstructured":"Singh D, Kumar A. Next-generation nanocarriers for precision antitumor therapy: from passive targeting to intelligent response. Explor Target Antitumor Ther. 2025;6:1002355. https:\/\/doi.org\/10.37349\/etat.2025.1002355.","journal-title":"Explor Target Antitumor Ther"},{"issue":"9","key":"3441_CR103","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s44222-024-00203-3","volume":"2","author":"A Dasgupta","year":"2024","unstructured":"Dasgupta A, Sofias AM, Kiessling F, Lammers T. Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact. Nature reviews bioengineering. 2024;2(9):714\u20136. https:\/\/doi.org\/10.1038\/s44222-024-00203-3.","journal-title":"Nature reviews bioengineering"},{"key":"3441_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119514","volume":"586","author":"WI El-Ghareb","year":"2020","unstructured":"El-Ghareb WI, Swidan MM, Ibrahim IT, Abd El-Bary A, Tadros MI, Sakr TM. 99mTc-doxorubicin-loaded gallic acid-gold nanoparticles (99mTc-DOX-loaded GA-Au NPs) as a multifunctional theranostic agent. Int J Pharm. 2020;586:119514. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119514.","journal-title":"Int J Pharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03441-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03441-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03441-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:08:36Z","timestamp":1780502916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03441-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":104,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["3441"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03441-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were carried out in adherence with the National Centre for Research and Technology Research Ethics Committee, Egypt (REC-NCRRT) guidelines with ethical approval number F\/18A\/25. This committee is following the 3Rs principles for animal experimentation and is organized and operated according to the CIOMS and ICLAS International Guiding Principles for Biomedical Research Involving Animals 2012.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could appear to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"205"}}